SCHEMBL12485483

SCHEMBL12485483

Cc1cc(N2CCCCC2C)nc(Nc2ccc(F)cc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MAPK1 P28482 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ NR4A1 P22736 1/20 0.48
▸ TP53 P04637 1/20 0.43
▸ SLC2A1 P11166 3/20 0.42
▸ BLM P54132 2/20 0.41
▸ GALR2 O43603 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ AURKB Q96GD4 1/20 0.40
▸ KCNH3 Q9ULD8 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HCRTR1 O43613 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12486622 0.85 MAPT (0.46) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12484778 0.85 MAPT (0.45) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12485615 0.85 MAPT (0.44) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12485536 0.84 SMN1; SMN2 (0.40) MAPTKDM4EL3MBTL1MAPK1MEN1
SCHEMBL12486466 0.83 CTNNB1 (0.44) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12484242 0.82 KCNH3 (0.40) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL12484199 0.81 MEN1 (0.63) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12485635 0.80 ALDH1A1 (0.62) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12486733 0.80 ALDH1A1 (0.62) MAPTKDM4EMAPK1MEN1KMT2A
SCHEMBL12485353 0.80 SYK (0.40) MAPTKDM4EMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072705-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2018-03-15 — — US claimed
EP-2678331-B1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2016-04-27 — — EP claimed
EP-2678331-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2014-01-01 — — EP claimed
US-20130331377-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2013-12-12 — — US claimed
CN-103391935-A Diaminopyrimidine derivatives and process for preparing same YUHAN CORP 2013-11-13 — — CN claimed
WO-2012115478-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2012-08-30 — — WO claimed
US-10640490-B2 Diaminopyrimidine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2020-05-05 — — US disclosed
US-20180072705-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2018-03-15 — — US disclosed
US-9850227-B2 Diaminopyrimidine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2017-12-26 — — US disclosed
EP-2678331-B1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2016-04-27 — — EP disclosed
EP-2678331-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2014-01-01 — — EP disclosed
US-20130331377-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2013-12-12 — — US disclosed
CN-103391935-A Diaminopyrimidine derivatives and process for preparing same YUHAN CORP 2013-11-13 — — CN disclosed
WO-2012115478-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2012-08-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130331377-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF HRH2, GIPR, SSTR4 MAPT 3132/4885KDM4E 3532/4885L3MBTL1 4496/4885
US-10640490-B2 Diaminopyrimidine derivatives and processes for the preparation thereof HRH2, GIPR, SSTR4 MAPT 3132/4885KDM4E 3532/4885L3MBTL1 4496/4885
US-20180072705-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF HRH2, GIPR, SSTR4 MAPT 3132/4885KDM4E 3532/4885L3MBTL1 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback